{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T04:10:43Z","timestamp":1748923843505,"version":"3.41.0"},"reference-count":23,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5,1]]},"DOI":"10.1210\/en.2016-1210","type":"journal-article","created":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T16:54:11Z","timestamp":1462467251000},"page":"1719-1721","source":"Crossref","is-referenced-by-count":4,"title":["Inhibition of Cholesterol Esterification in the Adrenal Gland by ATR101\/PD132301\u20132, A Promising Case of Drug Repurposing"],"prefix":"10.1210","volume":"157","author":[{"given":"Matthias","family":"Kroiss","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Diabetology, Department of Internal Medicine, University Hospital W\u00fcrzburg, University of W\u00fcrzburg; and Clinical Chemistry and Laboratory Medicine, University Hospital W\u00fcrzburg; and Comprehensive Cancer Center Mainfranken, University of W\u00fcrzburg, 97080 W\u00fcrzburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Fassnacht","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Diabetology, Department of Internal Medicine, University Hospital W\u00fcrzburg, University of W\u00fcrzburg; and Clinical Chemistry and Laboratory Medicine, University Hospital W\u00fcrzburg; and Comprehensive Cancer Center Mainfranken, University of W\u00fcrzburg, 97080 W\u00fcrzburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2016,10,15]]},"reference":[{"key":"2020071611575687200_B1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr Rev"},{"key":"2020071611575687200_B2","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1210\/jc.2013-3020","article-title":"Update in adrenocortical carcinoma","volume":"98","author":"Fassnacht","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611575687200_B3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assi\u00e9","year":"2014","journal-title":"Nat Genet"},{"key":"2020071611575687200_B4","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","article-title":"Combination chemotherapy in advanced adrenocortical carcinoma","volume":"366","author":"Fassnacht","year":"2012","journal-title":"N Engl J Med"},{"key":"2020071611575687200_B5","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1470-2045(15)70081-1","article-title":"Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study","volume":"16","author":"Fassnacht","year":"2015","journal-title":"Lancet Oncol"},{"key":"2020071611575687200_B6","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1021\/jm00037a016","article-title":"Inhibitors of acyl-CoA:cholesterol acyltransferase (ACAT). 7. Development of a series of substituted N-phenyl-N\u2032-[(1-phenylcyclopentyl)methyl]ureas with enhanced hypocholesterolemic activity","volume":"37","author":"Trivedi","year":"1994","journal-title":"J Med Chem"},{"key":"2020071611575687200_B7","first-page":"en20152052","article-title":"ATR-101, a selective and potent inhibitor of acyl-CoA acyltransferase 1, induces apoptosis in H295R adrenocortical cells and in the adrenal cortex of dogs","author":"LaPensee","year":"2016","journal-title":"Endocrinology"},{"key":"2020071611575687200_B8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0165-6147(91)90546-5","article-title":"Therapeutic potential of ACAT inhibitors as lipid lowering and anti-atherosclerotic agents","volume":"12","author":"Sliskovic","year":"1991","journal-title":"Trends Pharmacol Sci"},{"key":"2020071611575687200_B9","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMe068012","article-title":"Failure of ACAT inhibition to retard atherosclerosis","volume":"354","author":"Fazio","year":"2006","journal-title":"N Engl J Med"},{"key":"2020071611575687200_B10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jsbmb.2014.09.008","article-title":"Acyl-CoA:cholesterol acyltransferases (ACATs\/SOATs): enzymes with multiple sterols as substrates and as activators","volume":"151","author":"Rogers","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071611575687200_B11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.bi.52.070183.001255","article-title":"Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis","volume":"52","author":"Brown","year":"1983","journal-title":"Annu Rev Biochem"},{"key":"2020071611575687200_B12","doi-asserted-by":"crossref","first-page":"20747","DOI":"10.1016\/S0021-9258(19)36846-2","article-title":"Molecular cloning and functional expression of human acyl-coenzyme A:cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells","volume":"268","author":"Chang","year":"1993","journal-title":"J Biol Chem"},{"key":"2020071611575687200_B13","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.90926.2008","article-title":"Acyl-coenzyme A:cholesterol acyltransferases","volume":"297","author":"Chang","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071611575687200_B14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1388-1981(00)00144-X","article-title":"Mammalian acyl-CoA:cholesterol acyltransferases","volume":"1529","author":"Buhman","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"2020071611575687200_B15","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0022-3565(25)39484-X","article-title":"Divergent pharmacologic activities of PD 132301\u20132 and CL 277,082, urea inhibitors of acyl-CoA:cholesterol acyltransferase","volume":"267","author":"Krause","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"2020071611575687200_B16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1006\/taap.1996.0235","article-title":"Difference between normal and WHHL rabbits in susceptibility to the adrenal toxicity of an acyl-CoA:cholesterol acyltransferase inhibitor, FR145237","volume":"140","author":"Matsuo","year":"1996","journal-title":"Toxicol Appl Pharmacol"},{"key":"2020071611575687200_B17","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1177\/0192623313477753","article-title":"ACAT-selective and nonselective DGAT1 inhibition: adrenocortical effects\u2013a cross-species comparison","volume":"41","author":"Floettmann","year":"2013","journal-title":"Toxicol Pathol"},{"key":"2020071611575687200_B18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/019262339302100107","article-title":"Morphogenesis of a zone-specific adrenocortical cytotoxicity in guinea pigs administered PD 132301\u20132, an inhibitor of acyl-CoA:cholesterol acyltransferase","volume":"21","author":"Dominick","year":"1993","journal-title":"Toxicol Pathol"},{"key":"2020071611575687200_B19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/faat.1993.1029","article-title":"Subacute toxicity of a novel inhibitor of acyl-CoA: cholesterol acyltransferase in beagle dogs","volume":"20","author":"Dominick","year":"1993","journal-title":"Fundam Appl Toxicol"},{"key":"2020071611575687200_B20","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/0024-3205(95)00045-8","article-title":"Biochemical alterations in guinea pig adrenal cortex following administration of PD 132301\u20132, an inhibitor of acyl-CoA:cholesterol acyltransferase","volume":"56","author":"Wolfgang","year":"1995","journal-title":"Life Sci"},{"key":"2020071611575687200_B21","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1210\/en.2015-1367","article-title":"Mitotane inhibits sterol-O-acyl transferase 1 triggering lipid-mediated endoplasmic reticulum stress and apoptosis in adrenocortical carcinoma cells","volume":"156","author":"Sbiera","year":"2015","journal-title":"Endocrinology"},{"journal-title":"Endocr Relat Cancer","article-title":"ATR-101 disrupts mitochondrial functions in adrenocortical carcinoma cells and in vivo [published online February 3, 2016]","author":"Cheng","key":"2020071611575687200_B22"},{"journal-title":"Mol Cell Endocrinol","article-title":"The adrenal specific toxicant mitotane directly interacts with lipid membranes and alters membrane properties depending on lipid composition [published online March 18, 2016]","author":"Scheidt","key":"2020071611575687200_B23"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/157\/5\/1719\/8992813\/endo1719.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/157\/5\/1719\/8992813\/endo1719.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:54:58Z","timestamp":1748912098000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/157\/5\/1719\/2422491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,1]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2016-1210","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"type":"print","value":"0013-7227"},{"type":"electronic","value":"1945-7170"}],"subject":[],"published":{"date-parts":[[2016,5,1]]}}}